Literature DB >> 25979220

Hepatocellular Carcinoma: Review of Epidemiology, Screening, Imaging Diagnosis, Response Assessment, and Treatment.

Toshimasa Clark1, Suresh Maximin2, Jeffrey Meier3, Sajal Pokharel3, Puneet Bhargava2.   

Abstract

Hepatocellular carcinoma is a common malignancy for which prevention, screening, diagnosis, treatment, and surveillance demand a multidisciplinary approach. Knowledge of the underlying pathophysiology as well as advances in clinical management should be employed by radiologists to effectively communicate with hepatologists, surgeons, and oncologists. In this review article, we present recent developments in the clinical management of hepatocellular carcinoma.
Copyright © 2015 Mosby, Inc. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25979220     DOI： 10.1067/j.cpradiol.2015.04.004

Source DB:  PubMed          Journal:  Curr Probl Diagn Radiol        ISSN： 0363-0188


  75 in total

1.  Wls Expression Correlates with Tumor Differentiation and TNM Stage in Hepatocellular Carcinoma.

Authors:  Chao Zhou; Yuejun Sun; Shuwei Guo; Xiao Chen; Genchong Bao; Jiandong Wang
Journal:  Dig Dis Sci       Date:  2017-11-10       Impact factor: 3.199

2.  Augmenter of liver regeneration potentiates doxorubicin anticancer efficacy by reducing the expression of ABCB1 and ABCG2 in hepatocellular carcinoma.

Authors:  Yuan-Yuan Guo; Yuan Wu; Xiao-Wei Jia; Wei An
Journal:  Lab Invest       Date:  2017-08-21       Impact factor: 5.662

Review 3.  Optimizing the Combination of Immunotherapy and Trans-Arterial Locoregional Therapy for Stages B and C Hepatocellular Cancer.

Authors:  Matthew R Woeste; Anne E Geller; Robert C G Martin; Hiram C Polk
Journal:  Ann Surg Oncol       Date:  2021-01-03       Impact factor: 5.344

4.  Anti-tumor activity and mechanism of oligoclonal hepatocellular carcinoma tumor-infiltrating lymphocytes in vivo and in vitro.

Authors:  Wen-Chao Wang; Zong-Qin Zhang; Peng-Peng Li; Jun-Yong Ma; Lei Chen; Hai-Hua Qian; Le-Hua Shi; Zheng-Feng Yin; Bin Sun; Xiao-Feng Zhang
Journal:  Cancer Biol Ther       Date:  2019-04-24       Impact factor: 4.742

5.  The expression of FLNA and CLU in PBMCs as a novel screening marker for hepatocellular carcinoma.

Authors:  Rathasapa Patarat; Shoji Riku; Pattapon Kunadirek; Natthaya Chuaypen; Pisit Tangkijvanich; Apiwat Mutirangura; Charoenchai Puttipanyalears
Journal:  Sci Rep       Date:  2021-07-21       Impact factor: 4.379

6.  LncRNA FLJ33360 accelerates the metastasis in hepatocellular carcinoma by targeting miRNA-140/MMP9 axis.

Authors:  Zhenhui Lu; Yingzi Yu; Xiangchun Ding; Dong Jin; Genwang Wang; Yu Zhou; Yongzhao Zhu; Li Na; Yaqin He; Qi Wang
Journal:  Am J Transl Res       Date:  2020-02-15       Impact factor: 4.060

7.  MRI radiomics features predict immuno-oncological characteristics of hepatocellular carcinoma.

Authors:  Stefanie J Hectors; Sara Lewis; Cecilia Besa; Michael J King; Daniela Said; Juan Putra; Stephen Ward; Takaaki Higashi; Swan Thung; Shen Yao; Ilaria Laface; Myron Schwartz; Sacha Gnjatic; Miriam Merad; Yujin Hoshida; Bachir Taouli
Journal:  Eur Radiol       Date:  2020-02-21       Impact factor: 5.315

8.  [Musashi-1 positively regulates growth and proliferation of hepatoma cells in vitro].

Authors:  Jie Li; Kun Yan; Yi Yang; Hua Li; Zhidong Wang; Xin Xu
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2019-12-30

9.  HIPK2 suppresses tumor growth and progression of hepatocellular carcinoma through promoting the degradation of HIF-1α.

Authors:  Peizhan Chen; Xiaohua Duan; Xiaoguang Li; Jingquan Li; Qian Ba; Hui Wang
Journal:  Oncogene       Date:  2020-02-07       Impact factor: 9.867

10.  Amide proton transfer-weighted MRI for predicting histological grade of hepatocellular carcinoma: comparison with diffusion-weighted imaging.

Authors:  Yue Lin; Xiaojie Luo; Lu Yu; Yi Zhang; Jinyuan Zhou; Yuwei Jiang; Chen Zhang; Jintao Zhang; Chunmei Li; Min Chen
Journal:  Quant Imaging Med Surg       Date:  2019-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.